You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-XIAP antibodySee all XIAP primary antibodies ...
  • Description
    Rabbit polyclonal to XIAP
  • Specificityab59282 detects endogenous levels of total XIAP protein.
  • Tested applicationsIHC-P, ELISA more details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat
  • Immunogen

    A synthesized non phosphopeptide derived from human XIAP around the phosphorylation site of serine 87 (KVSPPN).

  • Positive controlHuman skeletal muscle tissue.

Properties

Applications

Our Abpromise guarantee covers the use of ab59282 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
IHC-P IHC-P: Use at an assay dependent dilution.
ELISA ELISA: 1/5000.

Target

  • FunctionApoptotic suppressor. Has E3 ubiquitin-protein ligase activity. Mediates the proteasomal degradation of target proteins, such as caspase-3, SMAC or AIFM1. Inhibitor of caspase-3, -7 and -9. Mediates activation of MAP3K7/TAK1, leading to the activation of NF-kappa-B.
  • Tissue specificityUbiquitous, except peripheral blood leukocytes.
  • Involvement in diseaseDefects in XIAP are the cause of lymphoproliferative syndrome X-linked type 2 (XLP2) [MIM:300635]. XLP is a rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus (EBV). Symptoms include severe or fatal mononucleosis, acquired hypogammaglobulinemia, pancytopenia and malignant lymphoma.
  • Sequence similaritiesBelongs to the IAP family.
    Contains 3 BIR repeats.
    Contains 1 RING-type zinc finger.
  • DomainThe first BIR domain is involved in interaction with TAB1/MAP3K7IP1 and is important for dimerization. The second BIR domain is sufficient to inhibit caspase-3 and caspase-7, while the third BIR is involved in caspase-9 inhibition. The interactions with SMAC and PRSS25 are mediated by the second and third BIR domains.
  • Post-translational
    modifications
    Ubiquitinated and degraded by the proteasome in apoptotic cells.
    Phosphorylation by PKB/AKT protects XIAP against ubiquitination and protects the protein against proteasomal degradation.
  • Cellular localizationCytoplasm.
  • Target information above from: UniProt accession P98170 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      AP 13 antibodyAPI3 antibodyApoptosis Inhibitor 3 antibody
      Baculoviral IAP repeat containing 4 antibodyBaculoviral IAP Repeat Containing Protein 4 antibodyBaculoviral IAP repeat-containing protein 4 antibodyBIRC 4 antibodyBIRC4 antibodyE3 ubiquitin-protein ligase XIAP antibodyhIAP-3 antibodyhIAP3 antibodyHILP antibodyIAP 3 antibodyIAP like protein antibodyIAP-3 antibodyIAP-like protein antibodyIAP3 antibodyILP 1 antibodyILP antibodyILP1 antibodyInhibitor of apoptosis protein 3 antibodyInhibitor of Apoptosis X Linked antibodyMammalian IAP Homologue A antibodyMIHA antibodyX linked IAP antibodyX linked inhibitor of apoptosis antibodyX linked inhibitor of apoptosis protein antibodyX-linked IAP antibodyX-linked inhibitor of apoptosis protein antibodyXiap antibodyXIAP_HUMAN antibodyXLP2 antibody
    see all

Anti-XIAP antibody images

  • Immunohistochemical analysis of paraffin-embedded human skeletal muscle tissue using ab59282 at a dilution of 1/50. Left hand image - without immunizing peptide; right hand image - with immunizing peptide.

References for Anti-XIAP antibody (ab59282)

ab59282 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab59282.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"